ImmuLogic Pharmaceutical Corp. (Abridged) Harvard Case Solution & Analysis

ImmuLogic Pharmaceutical Corp. (Abridged) Case Solution

ImmuLogic Pharmaceutical Corp., a development-stage medical business, is considering making a first offering of usual equity. The reasonsto get and issues of high-technology set-ups are checked out. The obstacles presented by "windows" for common products are feature.

immulogic pharmaceutical <a  href=

corporation case solution" width="288" height="288" /> immulogic pharmaceutical corporation case solution

This is just an excerpt. This case is about  FINANCE & ACCOUNTING

PUBLICATION DATE: December 09, 1992

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.